MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53

Glioblastoma multiforme is the most common primary malignancy in the brain and confers a uniformly poor prognosis. MicroRNAs have been shown to activate or inhibit tumorigenesis. Abnormalities in the p53 signaling pathway are found in various cancers and correlate with tumor formation. We examined t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Zhou, Xu, Wu, Weining, Zeng, Ailiang, Nie, Er, Jin, Xin, Yu, Tianfu, Zhi, Tongle, Jiang, Kuan, Wang, Yingyi, Zhang, Junxia, You, Yongping
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642619/
https://ncbi.nlm.nih.gov/pubmed/29050344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20528
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia